The Robot Rally is in Full Swing: Rapid Growth on the Horizon. BNGO Generates Over 3% Profit in Just One Week!
The Robot Rally is in Full Swing: Rapid Growth on the Horizon. BNGO Generates Over 3% Quick Profit with 2 Robots at Once. Swing-Trader-High-Volatility-Stocks-for-Active-Trading-TA-FA https://Swing-trader-Volatility-Balanced-Strategy-v-2-TA And that's just the tip of the iceberg. This week, all the robots combined have earned over 4%, surpassing all possible indices. These robots are designed for traders seeking high-volatility stocks while minimizing drawdowns during downtrends. Our AI robots utilize a range of technical indicators to identify reversal points in uptrends, allowing for balanced short and long positions to prevent significant drawdowns.
These robots are ideal for active traders capable of monitoring 40-50 trades simultaneously. With an average trade duration of one day, users can effectively utilize their capital without being tied up in prolonged trades.
To select stocks, our robots employ a proprietary method developed by our team of quants, evaluating the strength and quality of momentum in the most active stocks in the US market. A sophisticated algorithm, incorporating a pool of technical indicators processed through neural networks, determines entry points for positions.
Once a trade is initiated, our AI robots place a fixed "Take Profit" order at 3.5% of the position's opening price. For exiting a position, the robots utilize two options: a fixed stop loss at 3% of the opening price and a flexible trailing stop, helping preserve most of the profits if the market reverses. Subscribe to our robots and enjoy swift profitability.
BNGO in upward trend: price rose above 50-day moving average on January 22, 2026
BNGO moved above its 50-day moving average on January 22, 2026 date and that indicates a change from a downward trend to an upward trend. In of 21 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BNGO's RSI Oscillator exited the oversold zone, of 51 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on January 22, 2026. You may want to consider a long position or call options on BNGO as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BNGO just turned positive on January 22, 2026. Looking at past instances where BNGO's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BNGO advanced for three days, in of 218 cases, the price rose further within the following month. The odds of a continued upward trend are .
BNGO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BNGO entered a downward trend on January 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.331) is normal, around the industry mean (11.805). P/E Ratio (0.002) is within average values for comparable stocks, (159.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.507). BNGO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (0.185) is also within normal values, averaging (110.960).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BNGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of technologies for analysis of large biological molecules
Industry PharmaceuticalsOther
Advertisement